Vista Pharmaceuticals P/B Ratio
Vista Pharmaceuticals (VISTAPH) P/B ratio is 1.14 (Moderate), book value per share ₹37.50 vs Healthcare average P/B of -0.18 — Moderate - Reasonably valued relative to book value. For live price, earnings yield and the full fundamental profile, see VISTAPH stock price BSE.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
VISTAPH P/B Ratio — Valuation Insights & Book Value Analysis
Vista Pharmaceuticals price-to-book ratio interpretation, valuation status and historical context — current P/B 1.14 (Moderate). Check VISTAPH enterprise value to track the company's total market size over time.
- Current PB is 356.0% above historical average
- Trading at premium to sector average PB of -0.18
Vista Pharmaceuticals P/B Ratio Historical Trend
VISTAPH annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Also explore VISTAPH share price data to track price trends across different timeframes.
VISTAPH Historical P/B Ratio — Book Value Per Share & Year-End Price
Vista Pharmaceuticals annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 0.22 | ₹37.5 | ₹8.14 | ₹45 | Low |
| 2024 | 0.26 | ₹45.56 | ₹11.78 | ₹41 | Low |
| 2023 | 0.32 | ₹46.25 | ₹14.67 | ₹37 | Low |
| 2022 | 0.23 | ₹51.43 | ₹11.78 | ₹36 | Low |
| 2021 | 0.22 | ₹47.14 | ₹10.33 | ₹33 | Low |
VISTAPH vs Healthcare Peers — P/B Ratio Comparison
Vista Pharmaceuticals P/B 1.14 vs Healthcare average -0.18, median 0.67 — range -13.75–1.1.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sun Pharma Advanced Rese… | SPARC | -13.75 | ₹4,814 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.47 | ₹95 | Low |
| Parmax Pharma | PARMAX | -2.15 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.96 | ₹154 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |